7月31日的沙尾社区AI课堂里，不少中老年人用指尖触摸到了智能技术的温暖。年过六旬的王阿姨对着 手机说出"给女儿的生日祝福"，屏幕上随即生成带动画的电子贺卡，她笑着说："以前总怕被时代落 下，现在也能给孩子送'高科技礼物'了。" 7月31日，一场人工智能时代职场技能应用AI公益培训在深圳沙尾社区举行，为企业量身打造的"送教进 企"定制课程，为职工带来了实实在在的改变。这场持续AI技能普及行动，以"精准对接需求、深度融入 场景"为核心，不仅让AI技术从"实验室"走进"生产车间"，更探索出一套可复制的AI技能普及"深圳模 式"。 从企业车间到社区客厅的AI温度 作为年度收官阶段的"压轴戏"，7月三场特色培训精准覆盖不同群体，成为项目"分层赋能"理念的生动 注脚。7月27日的"全球关税战背景下AI赋能采购与供应链战略重构"课程上，学员们现场见证了"智能关 税计算工具"的实战价值，该技术将实实在在带来便利。 12个行业的AI渗透与50人次的特殊关怀 政企协同让AI红利普惠更多人 政府搭台、企业点题、机构研发、员工受益，深圳的"送AI进企业"模式，通过打破传统培训的壁垒，将 AI技能直接送到企业和员工身边，让更多人享受 ...

Group 1 - The Global X China Core Technology ETF has officially launched on the Hong Kong Stock Exchange, providing investors with a tool to diversify risks in technology stock investments, focusing on seven high-growth technology sectors and 30 leading Chinese technology companies [1] - The ETF tracks the Future Asset China Technology 30 Index, which includes the top 30 companies in China with potential global competitiveness, with an average market capitalization of $65 billion [1] - The top five sectors represented in the ETF are biotechnology (22%), semiconductors (17%), consumer electronics (17%), electric vehicles (15%), and batteries (9%) [1] Group 2 - China's manufacturing sector has rapidly expanded, now accounting for 30% of global manufacturing, ranking first in the world, with high-tech manufacturing growth outpacing traditional manufacturing [2] - In 2024, China's total R&D expenditure reached 3.6 trillion RMB, a year-on-year increase of 8.3%, maintaining its position as the second-largest globally [2] - Key industries such as semiconductors, renewable energy, and artificial intelligence are national strategic priorities, with domestic companies achieving technological independence and gaining a foothold in global markets [2] Group 3 - The rise of China's technology industry is expected to continue, with upgrades in high-end manufacturing, increased R&D investment, and deeper globalization [3] - The core technology sectors defined by the ETF are crucial for China's self-reliance in high-end technology, including biotechnology, semiconductors, electric vehicles, batteries, medical technology, robotics, consumer electronics, solar energy, and software [3] - The investment strategy of the Global X China Core Technology ETF focuses on 30 leading domestic companies, characterized by broad growth prospects, high R&D spending ratios, and attractive valuation advantages [3]

Group 1 - The Global X China Core Technology ETF (03448) has officially launched on the Hong Kong Stock Exchange, providing investors with a tool to diversify risks in technology stock investments, focusing on seven high-growth technology sectors and 30 leading Chinese technology companies [1] - The ETF tracks the Future Asset China Technology 30 Index, which includes the top 30 companies in China with potential global competitiveness, with an average market capitalization of $65 billion [1] - The top five sectors represented in the ETF are biotechnology (22%), semiconductors (17%), consumer electronics (17%), electric vehicles (15%), and batteries (9%) [1] Group 2 - Over the past few decades, China's manufacturing scale has rapidly expanded, now accounting for 30% of global manufacturing, ranking first in the world [2] - High-tech manufacturing has outpaced traditional manufacturing, indicating China's advancement in the global value chain [2] - In 2024, China's total R&D expenditure reached 3.6 trillion RMB, a year-on-year increase of 8.3%, maintaining its position as the second-largest globally [2] Group 3 - The rise of China's technology industry is expected to continue, with upgrades in high-end manufacturing, increased R&D investment, and deeper globalization [3] - The core technology sectors defined by the ETF are crucial for China's self-reliance in high-end technology and include biotechnology, semiconductors, electric vehicles, batteries, medical technology, robotics, consumer electronics, solar energy, and software [3] - The leading Chinese technology companies are anticipated to significantly increase their domestic market share while becoming global leaders [3]

Core Viewpoint - The Hong Kong Stock Exchange (HKEX) has launched a new policy called "Tech Company Special Line," which provides a confidential listing channel and lowers the threshold for specialized technology and biotechnology companies, attracting more tech firms to consider listing in Hong Kong [1][2]. Group 1: Applicable Entities - The policy is aimed at specialized technology companies (e.g., AI, chips, new energy) and biotechnology companies (e.g., innovative drugs, medical devices), particularly those in early stages or with non-commercialized products [3][4]. - Core thresholds include being classified under HKEX's definitions of "specialized technology" (Chapter 18C) or "biotechnology" (Chapter 18A) [4][5]. Group 2: Self-Assessment and Application Process - Companies must assess their eligibility by checking if they meet the criteria outlined in the self-assessment form available on the HKEX website [8]. - If uncertain, companies can fill out the inquiry form and send it to HKEX for preliminary feedback within one week [9]. Group 3: Confidential Submission Process - The first step involves signing a Non-Disclosure Agreement (NDA) with HKEX to ensure that submitted materials are only visible to the review team [11]. - Companies must submit a "confidential version" of their materials, including a checklist of required documents [12][13]. - The review team will provide feedback within 30 days, focusing on technical feasibility and compliance [14]. Group 4: Exclusive Services of "Tech Company Special Line" - Companies can receive one-on-one guidance from HKEX experts, including interpretations of listing rules and fundraising strategies [16]. - Eligible companies can benefit from a fast-track review process, reducing the review period to 30 days [17]. - Flexible equity design is allowed, enabling founders to retain control without additional proof of "innovation" [18]. Group 5: Common Pitfalls to Avoid - Companies should provide clear descriptions of their technology and avoid vague claims without supporting evidence [21]. - Transparency in related-party transactions is crucial to avoid compliance issues [22]. - Establishing a diverse investor base is important to strengthen investor relations [24]. Group 6: Post-Listing Compliance - Continuous information disclosure is required, including updates on technological commercialization and significant collaborations [27]. - Companies are encouraged to maintain market value by releasing quarterly research updates and engaging with analysts [28]. - A green channel for refinancing allows specialized companies to issue new shares through a simplified process [29]. Group 7: Comparison with Other Markets - The HKEX's "Tech Company Special Line" offers no profitability requirement, a shorter review period, and lower information disclosure pressure compared to A-shares and U.S. markets [30][31].

Group 1 - The US dollar index increased by 0.56%, currently at 99.439 points before the Federal Reserve's interest rate decision [1] - The yield on the 10-year US Treasury bond narrowed to less than 2.8 basis points, reported at 4.3481%, while the 2-year Treasury yield rose by 1.6 basis points, falling below 3.89% [1] Group 2 - Spot gold decreased by 0.76%, currently at $3301 [2] - The S&P 500 index rose by 0.23%, the Dow Jones remained roughly flat, the Nasdaq increased by 0.43%, the biotechnology index rose by 1%, the Philadelphia semiconductor index increased by 1.2%, the banking index rose by 0.5%, and the Russell 2000 index increased by 0.9% [2]

Group 1 - Major industry ETFs showed mixed performance, with the biotechnology and semiconductor ETFs both rising by 0.7% [1] - The biotechnology index ETF is currently priced at 134.78, reflecting an increase of 0.93 (+0.69%) with a total market value of 10.702 billion and a year-to-date change of +2.04% [2] - The semiconductor ETF is priced at 294.90, up by 2.00 (+0.68%), with a total market value of 34.86 billion and a year-to-date increase of +21.77% [2] Group 2 - The global airline ETF decreased by 0.8%, currently priced at 24.05, down by 0.20 (-0.82%), with a total market value of 0.0757575 billion and a year-to-date decline of -5.13% [1][2] - The utility ETF increased by 0.51%, priced at 85.01, with a total market value of 12.341 billion and a year-to-date change of +13.90% [2] - The financial sector ETF rose by 0.23%, priced at 52.92, with a total market value of 589.02 billion and a year-to-date increase of +10.27% [2]

Group 1 - The China Securities Regulatory Commission (CSRC) has optimized the registration review process for Hong Kong mutual recognition funds to enhance investor protection and ensure stable operations of these funds, requiring a minimum asset scale of 200 million RMB in the year prior to application [1] - Several small and medium-sized public fund companies have begun shutting down their mobile applications due to low user engagement and high operational costs, with companies like Ping An Fund and Guotai Junan Fund announcing similar plans [1] Group 2 - The Ministry of Finance has allocated a budget of approximately 90 billion RMB for childcare subsidies this year, with the central government covering about 90% of the funding needed for local governments [2] - In the first half of the year, 10 healthcare companies have listed in Hong Kong, raising a total of 2.1 billion USD, while 35 more companies have submitted listing applications [2] - A report indicates that by 2024, the revenue share of self-developed Chinese games from overseas sales is expected to reach 33.62%, with the Chinese and US gaming markets projected to be worth 47 billion USD and 46.1 billion USD respectively [2] Group 3 - Giant Star Legend has announced a partnership with Yushu Technology to develop consumer-grade robots, with plans to allocate approximately 38.2% of their recent fundraising for expanding retail channels, including vending machines and smart devices [3] - Huawei has launched its new flagship tablet, the MatePad Pro, featuring HarmonyOS 5 and starting at a price of 3,999 RMB [3] Group 4 - Greenland Holdings has refuted rumors regarding its CEO's disappearance, confirming that he is on personal leave but remains in his position [4] - Glencore plans to cut costs by 1 billion USD and has raised its long-term profit forecast for its commodities trading division for the first time since 2017, with expected profits now between 2.3 billion and 3.5 billion USD [4] - Zhongwang Software is facing a copyright infringement lawsuit from Autodesk in the US, which the company intends to contest vigorously [4] Group 5 - Pudong Construction reported a 1.89% decrease in the number of new engineering projects signed in Q2, with a 22.53% drop in project value to 3.278 billion RMB [5] - Anhui Construction announced a slight increase of 0.65% in new contract value for its engineering business, totaling 33.523 billion RMB [5] - Sinopec Oilfield Services has won a contract worth 3.597 billion RMB for a natural gas pipeline project, accounting for 4.44% of its projected revenue for 2024 [5] - Inner Mongolia Huadian reported a decline in revenue by 8.75% to 9.827 billion RMB and a net profit drop of 11.91% to 1.557 billion RMB for the first half of the year [5] Group 6 - Weihong Co. reported a 9.51% increase in revenue to 260 million RMB for the first half of the year, but a 28.86% decrease in net profit to approximately 29.25 million RMB [6] Group 7 - The Shanghai Composite Index rose by 0.17% despite a mixed performance in the market, with significant declines in high-profile stocks, while sectors like film, oil and gas, and baby products saw gains [7]

（编辑 袁冠琳） 证券日报网讯 四川双马7月30日在互动平台回答投资者提问时表示，未来公司将持续推动核心业务的深 入发展，聚焦于空间大、成长性好、盈利能力良好的生物科技等领域，延伸寻找有协同效应的业务，确 保长期的可持续发展和增长，为股东创造持续的股东回报。若涉及相关情况，公司将根据相关法律法规 及时履行信息披露义务。 ...

据了解，中华香港生物科技指数选股范畴包括：在香港上市的生物科技公司。 中华香港生物科技指数于2018年11月14日推出，指数基值2000点，成份股数目变动的只。 7月30日消息，截至当日收盘，中华香港生物科技指数报9498.3788点，下跌238.98点，跌幅2.45%。今 日最高9872.6885点，今日最低9282.4521点。 本文源自：金融界 作者：行情君 ...

上半年10家医疗健康公司在港上市 35家递交上市申请 智通财经7月30日电，最新数据显示，今年上半年已有10家医疗健康公司在港上市，融资总额达21亿美 元。截至本周，还有35家医疗健康行业公司已递交上市申请，其中包括16家根据第18A章递交申请的生 物科技公司。今年5月，港交易所推出"科企专线"，进一步便利了生物科技公司及特专科技公司申请上 市，并允许这些公司可以选择以保密形式提交上市申请。香港恒生生物科技指数年初至今涨幅已达 97%。（智通财经记者 赵昕睿） ...